Adaptive Biotechnologies
ADPT
#3276
Rank
NZ$8.51 B
Marketcap
NZ$52.58
Share price
-1.49%
Change (1 day)
117.87%
Change (1 year)

P/S ratio for Adaptive Biotechnologies (ADPT)

P/S ratio as of November 2026 (TTM): 15.8

According to Adaptive Biotechnologies 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 31.2. At the end of 2026 the company had a P/S ratio of 15.2.

P/S ratio history for Adaptive Biotechnologies from 2019 to 2026

PS ratio at the end of each year

Year P/S ratio Change
202615.268.38%
20259.0282.14%
20244.9518.83%
20234.17-29.34%
20225.90-77.02%
202125.7-68.79%
202082.286.63%
201944.0

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
HCA Healthcare
HCA
1.32-91.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Premier
PINC
2.33-85.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Community Health Systems
CYH
0.0271-99.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Select Medical Holdings
SEM
0.3706-97.65%๐Ÿ‡บ๐Ÿ‡ธ USA